The market certainly believes this - but it's got to the stage that even with a cut dividend it's still very good value. It must be just about book value by now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025